SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001179110-18-008621
Filing Date
2018-06-15
Accepted
2018-06-15 16:29:22
Documents
2
Period of Report
2018-06-14

Document Format Files

Seq Description Document Type Size
1 FORM 4 - edgar.html 4  
1 FORM 4 - edgar.xml 4 4069
2 ex24nashat.txt EX-24 4181
  Complete submission text file 0001179110-18-008621.txt   9702
Mailing Address 620 MEMORIAL DRIVE SUITE 300 CAMBRIDGE MA 02139
Business Address 620 MEMORIAL DRIVE SUITE 300 CAMBRIDGE MA 02139 617-744-1340
Syros Pharmaceuticals, Inc. (Issuer) CIK: 0001556263 (see all company filings)

IRS No.: 453772460 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 10835 ROAD TO THE CURE SUITE 205 SAN DIEGO CA 92121
Business Address
Nashat Amir (Reporting) CIK: 0001575843 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37813 | Film No.: 18902556